Accelerating Personalized Medicine
Providing CLIA/CAP next-generation sequencing (NGS) services and testing solutions to help healthcare providers develop and deliver precision and personalized medicine.
ArcherDX, Inc. Clinical Sequencing Services is performed in the ArcherDX CLIA (Clinical Laboratory Improvements Amendment)-certified and CAP (College of American Pathologists)-accredited Clinical Services Laboratory. The ArcherDX sequence information is generated by licensed personnel using an analytically validated process. Consistent with laboratory developed tests, it has not been cleared or approved by the U.S. Food and Drug Administration.
This sequencing information can be analyzed to potentially aid physicians in helping support therapeutic decision making. Patients will not receive medical results, or a diagnosis, or a recommendation for treatment from ArcherDX. If any questions or concerns arise about what is learned through this sequencing information, patients should contact their treating physician or a genetic counselor. Currently ArcherDX does not accept orders for ArcherDX Clinical Sequencing Services from New York.